| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3019 | |||||||||||||||||||||||
| Submitter : | Mrs. Mary Torres | Date & Time: | 12/12/2006 09:12:22 | |||||||||||||||||||||
| Organization : | Mrs. Mary Torres | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Do not use the morally objectionable practice of using aborted fetal cell lines in the production of vaccines or other products. My family and I will refuse to use any product that has been developed using aborted fetal tissue. Thank you. | ||||||||||||||||||||||||